149 related articles for article (PubMed ID: 36868012)
1. The importance of hsa-miR-28 in human malignancies.
Hosseini SF; Javanshir-Giv S; Soleimani H; Mollaei H; Sadri F; Rezaei Z
Biomed Pharmacother; 2023 May; 161():114453. PubMed ID: 36868012
[TBL] [Abstract][Full Text] [Related]
2. Dysregulated expression and functions of microRNA-330 in cancers: A potential therapeutic target.
Jafarzadeh A; Paknahad MH; Nemati M; Jafarzadeh S; Mahjoubin-Tehran M; Rajabi A; Shojaie L; Mirzaei H
Biomed Pharmacother; 2022 Feb; 146():112600. PubMed ID: 34968919
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-221: biogenesis, function and signatures in human cancers.
Abak A; Amini S; Sakhinia E; Abhari A
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3094-3117. PubMed ID: 29863255
[TBL] [Abstract][Full Text] [Related]
5. hsa-miR-20b-5p and hsa-miR-363-3p Affect Expression of
Drobna M; Szarzyńska B; Jaksik R; Sędek Ł; Kuchmiy A; Taghon T; Van Vlierberghe P; Szczepański T; Witt M; Dawidowska M
Cells; 2020 May; 9(5):. PubMed ID: 32380791
[TBL] [Abstract][Full Text] [Related]
6. A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder.
Inamoto T; Uehara H; Akao Y; Ibuki N; Komura K; Takahara K; Takai T; Uchimoto T; Saito K; Tanda N; Yoshikawa Y; Minami K; Hirano H; Nomi H; Kato R; Hayashi T; Azuma H
Dis Markers; 2018; 2018():5468672. PubMed ID: 30026881
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-493-5p-mediated repression of the MYCN oncogene inhibits hepatic cancer cell growth and invasion.
Yasukawa K; Liew LC; Hagiwara K; Hironaka-Mitsuhashi A; Qin XY; Furutani Y; Tanaka Y; Nakagama H; Kojima S; Kato T; Ochiya T; Gailhouste L
Cancer Sci; 2020 Mar; 111(3):869-880. PubMed ID: 31883160
[TBL] [Abstract][Full Text] [Related]
8. miR-142-3p/5p role in cancer: From epigenetic regulation to immunomodulation.
Zareifar P; Ahmed HM; Ghaderi P; Farahmand Y; Rahnama N; Esbati R; Moradi A; Yazdani O; Sadeghipour Y
Cell Biochem Funct; 2024 Mar; 42(2):e3931. PubMed ID: 38379239
[TBL] [Abstract][Full Text] [Related]
9. Identification of MicroRNAs as Breast Cancer Prognosis Markers through the Cancer Genome Atlas.
Chang JT; Wang F; Chapin W; Huang RS
PLoS One; 2016; 11(12):e0168284. PubMed ID: 27959953
[TBL] [Abstract][Full Text] [Related]
10. MiRNAs Mediate GDNF-Induced Proliferation and Migration of Glioma Cells.
Zhang BL; Dong FL; Guo TW; Gu XH; Huang LY; Gao DS
Cell Physiol Biochem; 2017; 44(5):1923-1938. PubMed ID: 29224008
[TBL] [Abstract][Full Text] [Related]
11. Abnormal regulation of microRNAs and related genes in pediatric β-thalassemia.
Wang H; Chen M; Xu S; Pan Y; Zhang Y; Huang H; Xu L
J Clin Lab Anal; 2021 Sep; 35(9):e23945. PubMed ID: 34398996
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA signature for estimating the survival time in patients with bladder urothelial carcinoma.
Yerukala Sathipati S; Tsai MJ; Shukla SK; Ho SY; Liu Y; Beheshti A
Sci Rep; 2022 Mar; 12(1):4141. PubMed ID: 35264666
[TBL] [Abstract][Full Text] [Related]
13. Functional Role of microRNA-23b-3p in Cancer Biology.
Grossi I; Salvi A; Baiocchi G; Portolani N; De Petro G
Microrna; 2018; 7(3):156-166. PubMed ID: 29962353
[TBL] [Abstract][Full Text] [Related]
14. Determination of Dysregulated miRNA Expression Levels by qRT-PCR after the Application of Usnic Acid to Breast Cancer.
Tanman Ü; Yangın S; Cansaran-Duman D
Anticancer Agents Med Chem; 2020; 20(5):548-558. PubMed ID: 31549595
[TBL] [Abstract][Full Text] [Related]
15. Identification of the differential expression of genes and upstream microRNAs in small cell lung cancer compared with normal lung based on bioinformatics analysis.
Li X; Ma C; Luo H; Zhang J; Wang J; Guo H
Medicine (Baltimore); 2020 Mar; 99(11):e19086. PubMed ID: 32176034
[TBL] [Abstract][Full Text] [Related]
16. Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells.
Jiang L; Huang Q; Zhang S; Zhang Q; Chang J; Qiu X; Wang E
BMC Cancer; 2010 Jun; 10():318. PubMed ID: 20569443
[TBL] [Abstract][Full Text] [Related]
17. Analysis of microRNA (miRNA) expression profiles reveals 11 key biomarkers associated with non-small cell lung cancer.
Wang K; Chen M; Wu W
World J Surg Oncol; 2017 Sep; 15(1):175. PubMed ID: 28927412
[TBL] [Abstract][Full Text] [Related]
18. A Novel Necroptosis-Related miRNA Signature for Predicting the Prognosis of Breast Cancer Metastasis.
Zheng L; Wang J; Jiang H; Dong H
Dis Markers; 2022; 2022():3391878. PubMed ID: 35371342
[TBL] [Abstract][Full Text] [Related]
19. The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis.
Li H; Xie S; Liu M; Chen Z; Liu X; Wang L; Li D; Zhou Y
Int J Oncol; 2014 Jul; 45(1):197-208. PubMed ID: 24805774
[TBL] [Abstract][Full Text] [Related]
20. Dysregulated Serum MiRNA Profile and Promising Biomarkers in Dengue-infected Patients.
Ouyang X; Jiang X; Gu D; Zhang Y; Kong SK; Jiang C; Xie W
Int J Med Sci; 2016; 13(3):195-205. PubMed ID: 26941580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
